Depression

The Pharmacy Times® Depression Resource Center is a comprehensive resource for clinical news and expert insights on treatments for the different forms of depression and its symptoms.


Latest News

https://mjh.sanity.studio/pharmacytimes/structure/article;f92c7f62-819f-4824-89b7-593f5761b127%2Ctemplate%3Darticle
Esketamine Receives FDA Approval for Adults With Treatment-Resistant Depression

January 21st 2025

Esketamine targets glutamate, the most abundant neurotransmitters in the brain.

Cardiovascular, Depression, Inflammation | Image Credit: Maridav | stock.adobe.com
Systemic Immune-Inflammation Index Associated With Increased Risk of Depressive Symptoms

January 8th 2025

Teenager struggling with anxiety -- Image credit: kieferpix | stock.adobe.com
Study Finds Nearly 75% of Adolescents Experience Depression, Anxiety

January 1st 2025

Long-Term Data On Olanzapine and Samidorphan Highlight Maintained Schizophrenia Symptom Control
Long-Term Data On Olanzapine and Samidorphan Highlight Maintained Schizophrenia Symptom Control

December 6th 2024

Woman with postpartum depression -- Image credit: kieferpix | stock.adobe.com
PPD Rates Increase Among All Racial Groups, but Asian/Pacific Islander and Black Patients See Highest Increases

November 26th 2024

More News